Epidemiology of invasive group A streptococcal infections in Norway 2010–2014: A retrospective cohort study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 35, Issue 10, 2016, Pages 1639-1648

  Naseer, U ^a,b   Steinbakk, M ^a   Blystad, H ^a   Caugant, D A ^a,c  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; TETRACYCLINE; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; STREPTOCOCCAL M PROTEIN;

ABSCESS; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTHRITIS; ARTICLE; CHILD; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SURVEILLANCE; ENDOCARDITIS; ERYSIPELAS; FEMALE; GROUP A STREPTOCOCCAL INFECTION; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NECROTIZING FASCIITIS; NEWBORN; NORWAY; OSTEOMYELITIS; PNEUMONIA; PRIORITY JOURNAL; PYELONEPHRITIS; RETROSPECTIVE STUDY; SEPSIS; CLASSIFICATION; CLUSTER ANALYSIS; GENETIC VARIATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; MIDDLE AGED; PRESCHOOL CHILD; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; NORWAY; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 84975698797     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-016-2704-y     Document Type: Article

References (30)

1. Cunningham MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13(3):470–511
2. Beall B, Facklam R, Thompson T (1996) Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 34(4):953–958
3. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR (2009) Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 9(10):611–616. doi:10.1016/S1473-3099(09)70178-1
4. Martin PR, Hoiby EA (1990) Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis 22(4):421–429. doi:10.3109/00365549009027073
5. Hoiby EA, Hasseltvedt V (1995) Increased incidence of severe Streptococcus group A infections in Noway during the last 10 years. New outbreak 1993-94. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 115(25):3131–3136
6. Meisal R, Andreasson IK, Hoiby EA, Aaberge IS, Michaelsen TE, Caugant DA (2010) Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles. J Clin Microbiol 48(3):842–851. doi:10.1128/JCM.01312-09
7. Meisal R, Hoiby EA, Aaberge IS, Caugant DA (2008) Sequence type and emm type diversity in Streptococcus pyogenes isolates causing invasive disease in Norway between 1988 and 2003. J Clin Microbiol 46(6):2102–2105. doi:10.1128/JCM.00363-08
8. Meisal R, Hoiby EA, Caugant DA, Musser JM (2010) Molecular characteristics of pharyngeal and invasive emm3 Streptococcus pyogenes strains from Norway, 1988-2003. Eur J Clin Microbiol Infect Dis: Off publ Eur Soc Clin Microbiol 29(1):31–43. doi:10.1007/s10096-009-0814-5
9. Siljander T, Lyytikainen O, Vahakuopus S, Snellman M, Jalava J, Vuopio J (2010) Epidemiology, outcome and emm types of invasive group A streptococcal infections in Finland. Eur J Clin Microbiol Infect Dis: Off publ Eur Soc Clin Microbiol 29(10):1229–1235. doi:10.1007/s10096-010-0989-9
10. Luca-Harari B, Ekelund K, van der Linden M, Staum-Kaltoft M, Hammerum AM, Jasir A (2008) Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004. J Clin Microbiol 46(1):79–86. doi:10.1128/JCM.01626-07
11. Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH (2003) Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis: Off Publ InfectDis Soc Am 37(9):1189–1193. doi:10.1086/379013
12. Luca-Harari B, Darenberg J, Neal S, Siljander T, Strakova L, Tanna A, Creti R, Ekelund K, Koliou M, Tassios PT, van der Linden M, Straut M, Vuopio-Varkila J, Bouvet A, Efstratiou A, Schalen C, Henriques-Normark B, Strep ESG, Jasir A (2009) Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 47(4):1155–1165. doi:10.1128/JCM.02155-08
13. O’Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, Albanese BA, Farley MM, Barrett NL, Spina NL, Beall B, Harrison LH, Reingold A, Van Beneden C, Active Bacterial Core Surveillance T (2007) The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis: Off Publ Infect Dis Soc Am 45(7):853–862. doi:10.1086/521264
14. Aziz RK, Kotb M (2008) Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 14(10):1511–1517. doi:10.3201/eid1410.071660
15. Bessen DE, Lizano S (2010) Tissue tropisms in group A streptococcal infections. Future Microbiol 5(4):623–638. doi:10.2217/fmb.10.28
16. Nielsen HU, Hammerum AM, Ekelund K, Bang D, Pallesen LV, Frimodt-Moller N (2004) Tetracycline and macrolide co-resistance in Streptococcus pyogenes: co-selection as a reason for increase in macrolide-resistant S. pyogenes? Microb Drug Resist 10(3):231–238. doi:10.1089/mdr.2004.10.231
17. Darenberg J, Henriques-Normark B, Lepp T, Tegmark-Wisell K, Tegnel A, Widgren K (2013) Increased incidence of invasive group A streptococcal infections in Sweden, January 2012-February 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 18(14):20443
18. Smit PW, Lindholm L, Lyytikainen O, Jalava J, Patari-Sampo A, Vuopio J (2015) Epidemiology and emm types of invasive group A streptococcal infections in Finland, 2008-2013. Eur J Clin Microbiol Infect Dis: Off publ Eur Soc Clin Microbiol 34(10):2131–2136. doi:10.1007/s10096-015-2462-2
19. Enright MC, Spratt BG, Kalia A, Cross JH, Bessen DE (2001) Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect Immun 69(4):2416–2427. doi:10.1128/IAI.69.4.2416-2427.2001
20. Mentasti M, Fry NK, Afshar B, Palepou-Foxley C, Naik FC, Harrison TG (2012) Application of Legionella pneumophila-specific quantitative real-time PCR combined with direct amplification and sequence-based typing in the diagnosis and epidemiological investigation of Legionnaires’ disease. Eur J Clin Microbiol Infect Dis: Off publ Eur Soc Clin Microbiol 31(8):2017–2028. doi:10.1007/s10096-011-1535-0
21. Turner CE, Abbott J, Lamagni T, Holden MT, David S, Jones MD, Game L, Efstratiou A, Sriskandan S (2015) Emergence of a new highly successful acapsular group A streptococcus clade of genotype emm89 in the United Kingdom. MBio 6(4), e00622. doi:10.1128/mBio.00622-15
22. Shea PR, Ewbank AL, Gonzalez-Lugo JH, Martagon-Rosado AJ, Martinez-Gutierrez JC, Rehman HA, Serrano-Gonzalez M, Fittipaldi N, Beres SB, Flores AR, Low DE, Willey BM, Musser JM (2011) Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010. Emerg Infect Dis 17(11):2010–2017. doi:10.3201/eid1711.110159
23. Darenberg J, Luca-Harari B, Jasir A, Sandgren A, Pettersson H, Schalen C, Norgren M, Romanus V, Norrby-Teglund A, Normark BH (2007) Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden. Clin Infect Dis: Off Publ InfectDis Soc Am 45(4):450–458. doi:10.1086/519936
24. Imohl M, Reinert RR, Ocklenburg C, van der Linden M (2010) Epidemiology of invasive Streptococcus pyogenes disease in Germany during 2003-2007. FEMS Immunol Med Microbiol 58(3):389–396. doi:10.1111/j.1574-695X.2010.00652.x
25. Chen YY, Huang CT, Yao SM, Chang YC, Shen PW, Chou CY, Li SY (2007) Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002. Diagn Microbiol Infect Dis 58(3):289–295. doi:10.1016/j.diagmicrobio.2007.01.013
26. Areas GP, Schuab RB, Neves FP, Barros RR (2014) Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil. Mem Inst Oswaldo Cruz 109(7):935–939
27. Syrogiannopoulos GA, Grivea IN, Al-Lahham A, Panagiotou M, Tsantouli AG, Michoula Ralf Rene Reinert AN, van der Linden M (2013) Seven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece. PLoS One 8(8), e71558. doi:10.1371/journal.pone.0071558
28. Tewodros W, Kronvall G (2005) M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns. J Clin Microbiol 43(9):4369–4376. doi:10.1128/JCM.43.9.4369-4376.2005
29. Sagar V, Kumar R, Ganguly NK, Chakraborti A (2008) Comparative analysis of emm type pattern of Group A Streptococcus throat and skin isolates from India and their association with closely related SIC, a streptococcal virulence factor. BMC Microbiol 8:150. doi:10.1186/1471-2180-8-150
30. Thapaliya D, O’Brien AM, Wardyn SE, Smith TC (2015) Epidemiology of necrotizing infection caused by Staphylococcus aureus and Streptococcus pyogenes at an Iowa hospital. J Infect Public Health 8(6):634–641. doi:10.1016/j.jiph.2015.06.003